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1. Introduction 
Membrane glycoproteins that are involved in the 
antigenicity of cell surface have been used as specific 
markers for characterizing various subpopulations of 
lymphocytes [ 11. Their glycoconjugate portions have 
different affinities for various lectins. Therefore, lectins 
with different sugar specificities are capable of char- 
acterizing the glycoproteins on celI surface membranes 
PI. 
Abbreviations: PBS, phosphate-buffered saline; buffer A, 
PBS containing 0.1% (w/v) sodium deoxycholate; buffer B, 
PBS containing 0.05% (w/v) Tween 20; buffer C, buffer B 
containing 2% (w/v) BSA; BSA, bovine serum albumin; PNA, 
peanut agglutinin; TLMA, rat T lymphocyte macrophage- 
associated antigen; ELISA, enzymelinked immunosorbent 
assay; NMR, nuclear magnetic resonance 
Glycolipid abbreviations: GlcCer, Glc@l -l)Cer; LacCer, 
Gal(pl-4)Glc@l- l)Cer; CTH, GbOse,Cer = Gal&-4)Gal- 
@l-4)Glc(pl-l)Cer; globoside, GbOse,Cer = GalNAc- 
~1-3)Gal(al-4)Gal(pl-4)Glc(~l-1)Cer; Forssman hapten 
glycolipid, IVJ-ol-GalNAc-GbOse,Cer = GalNAc(arl-3)- 
GalNAc(pl-3)Gal(ol-4)Gal~l-4)Gal(~3-l)Cer; asialo- 
GMl, GgOse,Cer = Gal(pl-3)GalNAc(p1-4)Gahf3-4)Gl~- 
(@l-l)Cer; GMl, II’-o-NeuAc-GgOse,Cer = Gal(pl-3) 
GalNAc(pl-4)Gal(pl-4)Glc@l-1)Cer; 
I 
(3-2a)NeuAc 
GDla, 113, IV3-cu-NeuAc-GgOse,Cer = Gal@-3)GalNao 
I 
(3-2a)NeuAc 
(pl-4)Gal(Pl-4)Glc(pl-l)Cer; 
I 
(3-2or)NeuAc 
fucosyl GMl, IIS~Y-NeuAc, IV3+Fuc-GgOse,Cer = 
Gal@l-3)GalNAc(pl-4)Gal(pl-4)Glc@l-1)Cer; asialo 
I I 
(2-1or)Fuc (3-2a)NeuAc 
GM2, GgOse,Cer = GalNAc(pl-4)Gal(pl-4)Glc(pl-1)Cer 
Lectins have the ability to bind with glycolipids as 
well as with glycoproteins [3,4]. Peanut agglutinin 
(PNA) which has a specificity for Gal@1 -3)GalNac 
[S] has been used to characterize thymocyte subpop- 
ulations [6]. Although the Gal@l-3)GalNAc struc- 
ture is present in many soluble glycoproteins among 
membrane glycocompounds, it has been identified in 
a few glycoproteins such as glycophorin, and in gly- 
cosphingolipids, GM1 and asialo GM1 . 
On the other hand, antibody against asialo GM1 , 
whose oligosaccharide structure is Gal@-3)GalNAc- 
@l-4)Gal@l-4)Glc, has been used as a probe capable 
of distinguishing immunologically competent cells of 
a particular type, such as natural killer cells, fetal thy- 
mocytes and suppressor cells of mice [7-lo]. The 
antibody also reacts with the mouse leukemia-derived, 
macrophage-like cells, M-l [ 111, mouse lung macro- 
phages [ 121, mouse activated macrophages [ 131, some 
of rat macrophages and T cells [ 14,151. Therefore, it 
is of interest to compare the reactivity of PNA to gly- 
colipids with the reaction of anti-asialo GM1 antibody 
to glycophorin, and to investigate the correlation 
between anti-asialo GM1 positive and PNA-receptor 
positive cells. 
2. Materials and methods 
Glycophorin from human erythrocytes was gener- 
ously donated by Dr M. Tomita (Showa University, 
Tokyo). GlcCer, IacCer, CTH and globoside were 
prepared from human erythrocyte membranes [ 161. 
Forssman hapten glycolipid was from sheep erythro- 
cytes [ 171. A&do GM1 was obtained by partial hydro- 
lysis of GM1 with 1 N formic acid (100°C for 1 h) 
[ 181. GM1 and GDla were from bovine brain [ 191, 
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and fucosyl GM1 was from boar testis [20]. Highly 
specific anti-asialo GM1 IgG antibody was prepared 
by affinity column chromatography on asialo GM1 
oligosaccharide S pharose 4B as in [21]. This purified 
antibody showed no cross-reaction with other glyco- 
lipids such as globoside, GM1 , asialo GM2, fucosyl 
GM1 and GDla [22]. 
2.1. Enzyme-linked immunosorbent QSSQY (ELBA) 
Reactivities of PNA (E. Y. Laboratory, San Mateo 
CA) and anti-asialo GM1 antibody with glycolipids 
and glycophorin were examined by the ELISA method 
essentially as in [23] with the modification of using 
buffer A for coating the micro ELISA-plate (Dynatech 
AG, Kloten) with the glycolipids [24]. Briefly, 50 111 
antigen solution (10 pg glycolipids in 1 ml buffer A) 
was added to microplate (96 wells) and incubated at 
37°C for 1 h for antigen adsorption. Then the plate 
was washed 3 times with buffer B. Buffer A (50 4) 
solution containing PNA at different concentrations 
was added to the plate, which was incubated at 37°C 
for 30 min. After another washing with buffer B, 
antibody against PNA (200 dilution, E. Y. Laboratory) 
was added, Incubation was continued for another 
30 min at 37°C and the plate was washed with buffer 
B. Peroxidase-conjugated goat anti-rabbit IgG (Miles 
Lab. Slough) in buffer C (50 4) was added and incu- 
bation continued for 30 more min at 37’C; 300 4 
3% (w/v) 5-amino salicylic acid in 0.05% HzOz solu- 
tion was added as a substrate and after 1 h, the 
absorption at 450 nm and at 660 nm was read. 
In the case of glycophorin, 50 111 untreated or 
neuraminidase-treated glycophorin in PBS (10 pg/ml 
or 1 pg/ml) was used for the adsorption to the micro- 
plate. The reaction with anti-a&lo GM1 was examined 
in the same way as above. Glycophorin (500 pg) was 
incubated with 100 I.~U of neuraminidase (Boehring, 
Mannheim from I’. cholerue) in 50 mM acetate buffer 
(pH 5.1) at 37°C for 24 h. 
2.2. Direct binding of PNA to glycolipids on thin- 
layer chromatogrum 
The method originally developed in [25] was modi- 
fied for application to a precoated silica gel thin-layer 
60 glass plate (E. Merck AG, Darmstadt) as detailed 
in [26]. Briefly, -1 pg glycolipid was applied on a 
thin-layer plate as a band <5 mm wide in each lane 
(1 X 9 cm). After development with chloroform/ 
methanol/water =60:35:8 (by vol.), the plate was air- 
dried completely, and PBS containing 1% (w/v) poly- 
vinyl pyrolidone was carefully layered on the plate. 
The remaining solution on the plate was removed by 
aspiration. This procedure was repeated twice more, 
and 1 ml PBS containing 50 c(g ‘*‘I-labelled PNA 
(100 000 dpm) which was prepared by using Na’*‘I 
(14.1 Ci/mmol, Amersham) and chloramine T [27], 
was carefully overlayered and allowed to stand for 
24 hat 4°C. The plate was dipped into 500 ml acetone 
to remove water. The air-dried plate was then exposed 
to Kodak X-O mat film at -80°C for 2 h. 
2.3. Qvotoxicity test for rat thymocytes 
PNA receptor-positive and PNA receptor-negative 
cells were prepared as in [6]. Cytotoxicity of anti- 
asialo GM1 antibody for rat thymocytes and PNA 
receptor-positive and PNA receptor-negative cells was 
tested by a method using a Coulter counter technique 
P81. 
2.4. PNA-Sepharose affinity column chromatography 
[3H]GM1 and [3H]asialo GM1 (10 mCi/mmol) 
which was prepared by using KB’H, (113 mCi/mmol) 
and PdC12 as the catalyst [29,30], were dissolved in 
200 fi buffer A. Ten microliters each of these glyco- 
lipid (ml 00 000 dpm) solutions was applied on a 
PNA-Sepharose column (1 ml bed vol., E. Y. Labo- 
ratory) which was equilibrated with buffer A. After 
application, the PNA-Sepharose column stood for 
1 h at room temperature for adsorption. Buffer A 
(2 ml) was applied for washing and the retained 
material was eluted with 4 ml 0.5 M galactosecon- 
taining buffer A. The eluates were collected in test 
tubes in 200 4. 
3. Results and discussions 
Reactivities of PNA and anti-a&do GM1 antibody 
with glycolipids and glycoproteins, respectively, were 
examined by ELISA. PNA Interacted only with asialo 
GM1 , but not with other glycolipids (fig.la). Anti- 
asialo GM1 antibody also preferentially recognized 
neuraminidase-treated glycophorin (fig.1 b). 
Glycophorin which is the major erythrocytes 
membrane glycoprotein, is known to have O-serine- 
or -threonine-linked Gal@l-3)GalNAc residues [31]. 
However, the oligosaccharides are usually sialylated at 
the 3rd position of the terminal galactose or 6th posi- 
tion of N-acetyl galactosamine. Therefore, the above 
result could be easily explained by postulating that 
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Fig. 1. Interactions of PNA and anti-asialo GM 1 antibody with glycolipids and glycophorin investigated by enzyme-linked immuno- 
sorbent assay. (a) Interaction of PNA with glycolipids: (o-e) asialo GMI; (o-o) GMl; (A-A) asialo GM2, fucosyl GMl, 
Forssman hapten glycolipid, globoside, and GDla. (b) Interaction of anti-asiolo GM1 with glycophorin and asialo GMl: (o-e) 
asialo GMl; (n---n) glycophorin; (o-o) neuraminidase-treated glycophorin. 
Fig.2. Direct visualization of the interaction of asialo GM1 by ‘251-labelled PNA on thin-layer chromatogram. (a) Autoradio- 
graphy: (1) mixture of GlcCer, LacCer, CTH and Globoside; (2) Forssman hapten glycolipid; (3) asialo GMl; (4) GMl. (b) Thin- 
layer chromatogram identical with that in (a), but visualized with orcinol reagents (115”C, for 15 min). 
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0.5 M Gal 
Fig.3. PNA-conjugated Sepharose affinity chromatography: 
(-) addition of 0.5 M galactose solution to the column; 
(o-o) asialo GMl; (e-o) GMl. 
neuraminidase treatment caused the galactose residue 
to become susceptible tobinding with anti-a&lo GM1 
antibody, and this result may explain why TLMA 
antigen, later identified as asialo GM1 , which was not 
detected in rat erythrocytes, appeared after neuramin- 
idase treatment at the cell surface [141. 
Direct binding of PNA with asialo GM1 was shown 
on thin-layer chromatogram (fig.2). LacCer, CTH, 
globoside and Forssman hapten glycolipids, the ter- 
minal sugar of which is either galactose or N-acetyl- 
galactosamine, did not interact with PNA. Further- 
more, no interaction of PNA with GM1 was observed, 
although cholera toxin could specifically interact 
with GM1 under the conditions used. 
The difference in specificity of PNA towards asialo 
GM1 and GM1 was further confirmed by PNA- 
Sepharose affinity column chromatography (fig.3): 
40-50% of the asialo GM1 was retained on the PNA- 
Sepharose column in contrast o only 10% of total 
GM1 bound in the column. This difference could be 
explained by postulating either that PNA preferen- 
tially recognizes the trisaccharide Gal@1 -3)GalNAc 
@I -4)Gal over the disaccharide Gal@ -3)GalNAc, 
or that the sialic acid residue of GM1 participates in
the interaction with the iV-acetyl group of GalNAc as 
suggested by NMR studies [32] and in hindering the 
binding of PNA with Gal@1 -3)GalNac. 
PNA receptor- and asialo GM1 -positive cell popu- 
lations in rat thymus were compared: 5-10% of the 
total cells of rat thymus are asialo GM1 positive; they 
were present in the cortico-medullar junction [ 221. 
Fig.4. Cytotoxicity test on rat thymocytes and PNA receptor- 
positive and PNA receptor-negative cells with anti-asialo GM1 
antibody and complement. The assay procedure is described 
in the text. 
However, thymocytes are known to be separated into 
cortical (immature) and medullar (mature) cells by 
their different PNA binding affinity [6]. Therefore, it 
is of interest o know whether asialo GMl-positive 
cells are PNA receptor-positive or not. Under condi- 
tions in which anti-asialo GM1 antibody lysed 20% of 
the total thymocytes, it lysed 3 1% of the PNA recep- 
tor-positive cells and 14% of the PNA receptor-nega- 
tive cells (fig.4). Therefore, it appears that PNA recep- 
tor-positive and asialo GMl-positive cell populations 
overlap considerably. 
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